News | Press Releases

December 2, 2013

Toshiba CT Delivers More Consistent Results with Adaptive Diagnostics Technology

Helps Eliminate Variability in Scanning with the Industry-Leading Solutions

CHICAGO, Dec. 2, 2013 - Lowering CT dose and improving workflow are not choices that clinicians should have to make, so Toshiba CT is providing industry-leading solutions to solve these challenges. To make complex exams easier, lower dose and improve diagnostic accuracy and reproducibility, Toshiba is introducing its suite of Adaptive Diagnostics CT technology.

Available as options across the Aquilion™ CT platform, Toshiba's Adaptive Diagnostics includes:

  • SURESubtraction™ has the ability to subtract bone and calcium from data sets, allowing clinicians to better visualize tumors or arteries at risk. Currently available for brain, bone, carotid and coronary artery (works-in-progress) exams.
  • Single Energy Metal Artifact Reduction (SEMAR) uses a raw data-based reconstruction to remove streak artifacts in images due to metallic implants in the body.
  • SURECardio™ Prospective with arrhythmia detection is a unique application that dramatically lowers patient dose during coronary CTA exams using a helical prospective acquisition. It automatically detects and adjusts to patients with irregular heartbeats, providing quicker and more consistent exam results.
  • Variable Helical Pitch (vHP) has the ability to automatically change an ECG-gated to a non-ECG-gated acquisition, reducing IV contrast and radiation dose. vHP can reduce radiation dose over the use of a single-gated pitch setting.
  • Dual Energy (pending FDA clearance) uses two energies during one volumetric or helical CT scan, providing clinicians with more data to help quantify and characterize anatomy and lesions.

"Today's healthcare environment is changing and there are new clinical challenges that our customers are facing," says Satrajit Misra, senior director, CT Business Unit, Toshiba. "Adaptive Diagnostics is an example of how Toshiba develops technologies that meet the needs of providers today and in the future, giving them the tools to improve quality of care while reducing costs."

Toshiba is showcasing its Aquilion product line and Adaptive Diagnostics technology at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Dec. 1-6, 2013 (Booth #7330, North Hall).

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation's website at

About Toshiba

Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.

Toshiba was founded in 1875, and today operates a global network of more than 550 consolidated companies, with 210,000 employees worldwide and annual sales surpassing 5.8 trillion yen (US$61.7 billion). Visit Toshiba's website at

* Aquilion, SURECardiio and SURESubtraction are trademarks of Toshiba Medical Systems Corporation.

Contact Us